Spire Healthcare Group Logo
GB00BNLPYF73
A117ZX
SPI.L

Spire Healthcare Group

Forecast

Buy
  0
Hold
  0
Sell
  1

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Spire Healthcare accepts takeover offer worth ÂŁ1.03 billion

    Spire Healthcare agreed to a takeover offer from a consortium that includes funds managed by Toscafund, Three Hills and Ares. Shareholders will receive 250 pence per share in cash, valuing the equity at around £1.03 billion. The stock then rose by more than 3% to 245.5 pence, reaching a one-year high. » More on de.investing.com


  • Takeover deadline for Spire Healthcare by Toscafund extended by one day

    Toscafund has extended the deadline to submit a binding offer for Spire Healthcare to Friday at 17:00 London time in order to finalise financing documents. The potential cash offer amounts to 250 pence per share; due diligence is complete and the transaction documentation is nearly final. Toscafund may reduce the offer under certain conditions, and there is no certainty that a binding offer will actually be made. » More on de.investing.com


  • Spire Healthcare: takeover deadline for Toscafund extended by one day to 4 September

    The board of Spire Healthcare said the deadline for a binding takeover offer from Toscafund Asset Management has been extended by one day to 4 September 2026. Toscafund announced a cash offer of 250 pence per share in May and confirmed that due diligence is complete, but still requires financing documentation and the final transaction documents. The offer remains subject to customary conditions, Toscafund reserves the right in certain circumstances to reduce the offer, and there is no certainty that a binding offer will actually be made. » More on de.investing.com


  • Spire Healthcare extends takeover deadline for offer from Toscafund to 21 August

    Spire Healthcare said the deadline for a binding takeover offer from Toscafund has been extended to 21 August 2026. Toscafund has submitted a revised, non-binding offer of 250 pence per share in cash with an option for unlisted rollover shares and has largely completed its due diligence. The extension is intended to enable completion of the financing arrangements; a binding offer remains subject to usual conditions and is not certain. » More on de.investing.com


  • Debbie White to succeed Sir Ian Cheshire as chair of Spire Healthcare

    Spire Healthcare said Sir Ian Cheshire will resign as chair on 30 September 2026. Debbie White, an independent non‑executive director since February 2023 and senior independent director since May 2023, will take on the role of designated chair with immediate effect and will assume the chair after Cheshire’s resignation. Sir Ian will be available in an advisory capacity during his six‑month notice period; Natalie Ceeney will take on the role of senior independent director. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Spire Healthcare Group has already paid €0.0173 in dividends. The last payout was in June.

Financials

In the last quarter, Spire Healthcare Group had revenue of €920.17M and net profit of -€13.7M

(EUR) June 2026
YoY
Revenue 920.17M -
Gross profit 343.83M -
Net profit -13.7M -
EBITDA 130.71M -

Fundamentals

Metric Value
Market capitalization
€1.19B
Number of shares
400.6M
52-week high/low
€2.99 - €1.68
Dividend yield
0.58%
Dividends TTM
€0.0173
Beta
0.87
P/E ratio
-526.60
PEG ratio
4.78
P/B ratio
1.37
P/S ratio
0.63

Company profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory care, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology care, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers diagnostics, in-patient, daycase, and out-patient care services through 40 hospitals and eight clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Name
Spire Healthcare Group
CEO
Justin Ash
Headquarters London, gl
United Kingdom
Website
IPO
07/18/2014
Employees 17,800

Ticker symbols

Exchange Symbol
London Stock Exchange
SPI.L
Frankfurt
S00.F
DĂĽsseldorf
S00.DU
London
SPI.L
MĂĽnchen
S00.MU
🍪

Parqet  uses cookies. Learn more